Barclays
OSCR icon

Barclays’s Oscar Health OSCR Stock Holding History

Barclays’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-350,000
Closed -$5.03M – 5322
2025
Q4 		$5.03M Buy
+350,000
New +$6.05M ﹤0.01% 2213

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays's OSCR Position: Q2 2026 in Review

Barclays reduced its Oscar Health (OSCR) stake by 23% in Q2 2026, selling an estimated $2.1M and leaving 329,785 shares worth $9.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Barclays first reported a position in OSCR in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.58M in Q4 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Barclays held 329,785 shares of Oscar Health worth $9.41M as of Q2 2026.
  • Barclays sold 97,721 Oscar Health shares in Q2 2026, an estimated $2.1M.
  • Oscar Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1510 holding.
  • Barclays first reported a position in Oscar Health in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Oscar Health position peaked at $9.58M in Q4 2025.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.